Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) Definition

Purpose There is a lack of a valid definition for skin ulcers in systemic sclerosis (SSc) to be used in clinical trials. Our aim was to develop a consensus definition for SSc skin ulcers based on the results of a systematic literature review (SLR) for skin ulcer definitions and expert opinion; and to evaluate its face validity, reliability and feasibility. Methods SLR for skin ulcer definitions was conducted using PubMed, Web of Science, and Cochrane library for articles published from inception to January 1st, 2016. SSc experts were to discuss the definition categories and vote for the relevant terms. Reliability of the definition was tested in a second expert meeting, seven SSc experts evaluated 7 SSc patients with skin lesions twice. Face validity and feasibility were evaluated by sending out case report forms (CRFs) to four SSc experts, who were each asked to use the definition in five patients. Results A total of 3464 abstracts and titles were screened, and 446 articles were fully evaluated. Of these, 66 met eligibility criteria and skin ulcer definitions were extracted. SSc experts discussed, refined, and voted on the consensus definition using nominal process. Kappa for inter-rater agreement was 0.51 and for intra-rater agreement was 0.90. The mean time to decide if the lesion is an ulcer was 7.4 seconds. All investigators endorsed the face validity of the new definition in the CRFs. Conclusions Using an SLR and a nominal technique, we developed a preliminary consensus-based definition of SSc skin ulcers. Face validity, feasibility and reliability were demonstrated for the developed definition.

[1]  A. Marr,et al.  Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials. , 2016, JAMA.

[2]  A. Murray,et al.  Does the Clinical Context Improve the Reliability of Rheumatologists Grading Digital Ulcers in Systemic Sclerosis? , 2016, Arthritis care & research.

[3]  C. Denton,et al.  Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry , 2015, Annals of the rheumatic diseases.

[4]  C. Denton,et al.  SAT0438 Clinical Characteristics of Systemic Sclerosis Patients with Digital Ulcer Disease Who Developed Gangrene: Data from the Duo Registry , 2015 .

[5]  Paul Martin,et al.  Wound repair and regeneration: Mechanisms, signaling, and translation , 2014, Science Translational Medicine.

[6]  M. Richard,et al.  Ischemic Digital Ulcers Affect Hand Disability and Pain in Systemic Sclerosis , 2014, Journal of Rheumatology.

[7]  P. Tugwell,et al.  Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. , 2014, Journal of clinical epidemiology.

[8]  L. March,et al.  Reliability of joint count assessment in rheumatoid arthritis: a systematic literature review. , 2014, Seminars in arthritis and rheumatism.

[9]  P. Tugwell,et al.  Updating the OMERACT Filter: Discrimination and Feasibility , 2014, The Journal of Rheumatology.

[10]  Ami A. Shah,et al.  Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis , 2014, Clinical Rheumatology.

[11]  M. Baron,et al.  The 15% Rule in Scleroderma: The Frequency of Severe Organ Complications in Systemic Sclerosis. A Systematic Review , 2013, The Journal of Rheumatology.

[12]  M. Matucci-Cerinic,et al.  Review: evidence that systemic sclerosis is a vascular disease. , 2013, Arthritis and rheumatism.

[13]  M. Moradi-Lakeh,et al.  Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients , 2013, Rheumatology International.

[14]  M. Silkey,et al.  Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry , 2012, Annals of the rheumatic diseases.

[15]  L. Mouthon,et al.  Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers , 2011, Arthritis care & research.

[16]  D. Conforti,et al.  Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. , 2010, Rheumatology.

[17]  L. Czirják,et al.  Repeated teaching courses of the modified Rodnan skin score in systemic sclerosis. , 2010, Clinical and experimental rheumatology.

[18]  T. Pincus,et al.  Joint counts to assess rheumatoid arthritis for clinical research and usual clinical care: advantages and limitations. , 2009, Rheumatic diseases clinics of North America.

[19]  D. Moher,et al.  Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Physical therapy.

[20]  T. Krieg,et al.  Interrelation of immunity and tissue repair or regeneration. , 2009, Seminars in cell & developmental biology.

[21]  J. Gerss,et al.  Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors , 2009, The British journal of dermatology.

[22]  Marina Anderson,et al.  Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis. , 2009, Arthritis and rheumatism.

[23]  E. Hachulla,et al.  Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study. , 2007, The Journal of rheumatology.

[24]  C. Denton,et al.  Digital ulcers: overt vascular disease in systemic sclerosis. , 2006, Rheumatology.

[25]  A. V. D. Ven,et al.  The Effectiveness of Nominal, Delphi, and Interacting Group Decision Making Processes , 1974 .

[26]  L. Rasero,et al.  Lidocaine controls pain and allows safe wound bed preparation and debridement of digital ulcers in systemic sclerosis: a retrospective study , 2016, Clinical Rheumatology.

[27]  O. Distler,et al.  Novel Aspects in the Pathophysiology of Peripheral Vasculopathy in Systemic Sclerosis. , 2013, Current rheumatology reviews.

[28]  M. Mayes,et al.  Bosentan treatment of digital ulcers related to systemic sclerosis : results from the RAPIDS-2 randomised , double-blind , placebo-controlled trial , 2010 .

[29]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.